Immunovant (IMVT) Debt Ratio (2018 - 2023)

Immunovant (IMVT) has 4 years of Debt Ratio data on file, last reported at 0.0 in Q1 2023.

• Quarterly Debt Ratio rose 160.02% year-over-year to 0.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.0 (up 160.02% YoY) and the FY2023 annual result came in at 0.0, up 160.02% from the prior year.
• Debt Ratio advanced to 0.0 in Q1 2023, from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.04 in Q2 2019 to a low of 0.0 in Q3 2020.
• A 4-year average of 0.01 and a median of 0.0 in 2019 frame the typical range for Debt Ratio.
• The widest YoY moves for Debt Ratio: up 595.27% in 2020, down 98.61% in 2020.
• Tracing IMVT's Debt Ratio over 4 years: stood at 0.02 in 2019, then plunged by 98.81% to 0.0 in 2020, then climbed by 12.35% to 0.0 in 2022, then jumped by 160.02% to 0.0 in 2023.
• The last three Debt Ratio figures came in at 0.0 (Q1 2023), 0.0 (Q1 2022), and 0.0 (Q3 2020), per Business Quant data.